UTRS
vs
S&P 500
UTRS
S&P 500
Over the past 12 months, UTRS has significantly outperformed S&P 500, delivering a return of +100% compared to the S&P 500's +14% growth.
Stocks Performance
UTRS vs S&P 500
Performance Gap
UTRS vs S&P 500
Performance By Year
UTRS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Minerva Surgical Inc
Glance View
Minerva Surgical, Inc. is a medical technology company, which engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. The company is headquartered in Santa Clara, California and currently employs 157 full-time employees. The company went IPO on 2021-10-22. The firm has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The firm offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.